212 related articles for article (PubMed ID: 21295991)
1. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement.
Keyl C; Uhl R; Beyersdorf F; Stampf S; Lehane C; Wiesenack C; Trenk D
Eur J Cardiothorac Surg; 2011 May; 39(5):e114-21. PubMed ID: 21295991
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
[TBL] [Abstract][Full Text] [Related]
3. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
Martin K; Knorr J; Breuer T; Gertler R; Macguill M; Lange R; Tassani P; Wiesner G
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):20-5. PubMed ID: 21272777
[TBL] [Abstract][Full Text] [Related]
4. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
5. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
7. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
Martin K; Wiesner G; Breuer T; Lange R; Tassani P
Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
[TBL] [Abstract][Full Text] [Related]
8. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients.
Murkin JM; Falter F; Granton J; Young B; Burt C; Chu M
Anesth Analg; 2010 Feb; 110(2):350-3. PubMed ID: 19996135
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation.
Madershahian N; Scherner M; Pfister R; Rudolph T; Deppe AC; Slottosch I; Kuhn E; Choi YH; Wahlers T
J Cardiothorac Surg; 2015 Mar; 10():45. PubMed ID: 25888231
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic Acid in cardiac surgery and postoperative seizures: a case report series.
Bell D; Marasco S; Almeida A; Rowland M
Heart Surg Forum; 2010 Aug; 13(4):E257-9. PubMed ID: 20719731
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
12. Tranexamic acid reduces blood transfusions in elderly patients undergoing combined aortic valve and coronary artery bypass graft surgery: a randomized controlled trial.
Greiff G; Stenseth R; Wahba A; Videm V; Lydersen S; Irgens W; Bjella L; Pleym H
J Cardiothorac Vasc Anesth; 2012 Apr; 26(2):232-8. PubMed ID: 21924636
[TBL] [Abstract][Full Text] [Related]
13. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
14. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors.
Manji RA; Grocott HP; Leake J; Ariano RE; Manji JS; Menkis AH; Jacobsohn E
Can J Anaesth; 2012 Jan; 59(1):6-13. PubMed ID: 22065333
[TBL] [Abstract][Full Text] [Related]
15. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Vonk AB; Meesters MI; Schats J; Romijn JW; Jansen EK; Boer C
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):135-9. PubMed ID: 21075830
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.
Montes FR; Pardo DF; Carreño M; Arciniegas C; Dennis RJ; Umaña JP
Ann Card Anaesth; 2012; 15(1):6-12. PubMed ID: 22234015
[TBL] [Abstract][Full Text] [Related]
18. Comparison of blood-sparing efficacy of ε-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery.
Martin K; Gertler R; Sterner A; MacGuill M; Schreiber C; Hörer J; Vogt M; Tassani P; Wiesner G
Thorac Cardiovasc Surg; 2011 Aug; 59(5):276-80. PubMed ID: 21425054
[TBL] [Abstract][Full Text] [Related]
19. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
20. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass.
Kalavrouziotis D; Voisine P; Mohammadi S; Dionne S; Dagenais F
Ann Thorac Surg; 2012 Jan; 93(1):148-54. PubMed ID: 22054656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
